Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > ICO Demonstrated Good Integrity Today

<< Previous

Bullboard Posts

Next >>

Post by blinkieon Dec 31, 2020 3:14pm

132 Views

Post# 32205069

ICO Demonstrated Good Integrity Today

By releasing the news today ....assuming when the venture was formally agreed to...demonstrated good integrity on ICOs part.

They could have waited until Monday for possibly greater impact?

I am really anxious to see WHO is doing all of the buying ???

I do not have access

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario